Health services deal volumes through April 30 declined by a modest 4 percent from 2023 levels, demonstrating continued resilience coming off the peak volumes of 2022. While the sector continues to be impacted by headwinds including increased regulatory pressure, dealmakers have become more accustomed to the current interest rate environment and have adapted to the correlated decline in price to earnings multiples. These factors, combined with broader market tailwinds such as capital availability and a need for sponsors to facilitate exits and return capital to limited partners, should continue to bolster deal activity throughout 2024.
Read the full article: PwC: Health Services – US Deals 2024 Midyear Outlook //
Source: https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html